Theravance Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2013
Total Assets: $25.2M
Liabilities Breakdown FY2013
Total Liabilities: $42.2M
Asset Breakdown
Total Assets: $25.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $0 | 0.0% |
| Accounts Receivable | $199.0K | 0.8% |
| Inventory | $10.4M | 41.3% |
| Property, Plant & Equipment | $10.2M | 40.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.3M | 17.2% |
Liabilities Breakdown
Total Liabilities: $42.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.9M | 16.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $35.3M | 83.6% |